Macrolides in Chronic Inflammatory Skin Disorders

Long-term therapy with the macrolide antibiotic erythromycin was shown to alter the clinical course of diffuse panbronchiolitis in the late 1980s. Since that time, macrolides have been found to have a large number of anti-inflammatory properties in addition to being antimicrobials. These observation...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullateef A. Alzolibani, Khaled Zedan
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/159354
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561086584324096
author Abdullateef A. Alzolibani
Khaled Zedan
author_facet Abdullateef A. Alzolibani
Khaled Zedan
author_sort Abdullateef A. Alzolibani
collection DOAJ
description Long-term therapy with the macrolide antibiotic erythromycin was shown to alter the clinical course of diffuse panbronchiolitis in the late 1980s. Since that time, macrolides have been found to have a large number of anti-inflammatory properties in addition to being antimicrobials. These observations provided the rationale for many studies performed to assess the usefulness of macrolides in other inflammatory diseases including skin and hair disorders, such as rosacea, psoriasis, pityriasis rosea, alopecia areata, bullous pemphigoid, and pityriasis lichenoides. This paper summarizes a collection of clinical studies and case reports dealing with the potential benefits of macrolides antibiotics in the treatment of selected dermatoses which have primarily been classified as noninfectious and demonstrating their potential for being disease-modifying agents.
format Article
id doaj-art-5e5cdd1a0c0248439018a6cd5bdacd8e
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-5e5cdd1a0c0248439018a6cd5bdacd8e2025-02-03T01:26:00ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/159354159354Macrolides in Chronic Inflammatory Skin DisordersAbdullateef A. Alzolibani0Khaled Zedan1Dermatology Department, College of Medicine, Qassim University, P.O. Box 30109, Buraidah 51477, Saudi ArabiaPediatric Department, College of Medicine, Qassim University, P.O. Box 30109, Buraidah 51477, Saudi ArabiaLong-term therapy with the macrolide antibiotic erythromycin was shown to alter the clinical course of diffuse panbronchiolitis in the late 1980s. Since that time, macrolides have been found to have a large number of anti-inflammatory properties in addition to being antimicrobials. These observations provided the rationale for many studies performed to assess the usefulness of macrolides in other inflammatory diseases including skin and hair disorders, such as rosacea, psoriasis, pityriasis rosea, alopecia areata, bullous pemphigoid, and pityriasis lichenoides. This paper summarizes a collection of clinical studies and case reports dealing with the potential benefits of macrolides antibiotics in the treatment of selected dermatoses which have primarily been classified as noninfectious and demonstrating their potential for being disease-modifying agents.http://dx.doi.org/10.1155/2012/159354
spellingShingle Abdullateef A. Alzolibani
Khaled Zedan
Macrolides in Chronic Inflammatory Skin Disorders
Mediators of Inflammation
title Macrolides in Chronic Inflammatory Skin Disorders
title_full Macrolides in Chronic Inflammatory Skin Disorders
title_fullStr Macrolides in Chronic Inflammatory Skin Disorders
title_full_unstemmed Macrolides in Chronic Inflammatory Skin Disorders
title_short Macrolides in Chronic Inflammatory Skin Disorders
title_sort macrolides in chronic inflammatory skin disorders
url http://dx.doi.org/10.1155/2012/159354
work_keys_str_mv AT abdullateefaalzolibani macrolidesinchronicinflammatoryskindisorders
AT khaledzedan macrolidesinchronicinflammatoryskindisorders